Acelity

Acelity was a medical technology company headquartered in San Antonio, Texas, focused on advanced wound care, negative-pressure wound therapy, and regenerative medicine. Its business was closely associated with KCI’s medical device and wound-care operations, serving hospitals, surgical teams, and other healthcare providers. Representative product lines associated with Acelity included the V.A.C. negative-pressure wound therapy systems, the PREVENA incision management system, and the ABTHERA open-abdomen therapy system. In 2019, 3M announced the acquisition of Acelity, and the company’s operations were subsequently incorporated into 3M’s healthcare business. Acelity is therefore generally regarded as a medical technology company that was absorbed into 3M rather than an independently operating public company today.

Acelity was a U.S. medical technology company whose business centered on advanced wound care, negative-pressure wound therapy, and regenerative medicine. Its operations were directly associated with KCI’s wound-care technologies and product portfolio, with hospitals and surgical settings representing important areas of use. Products associated with Acelity included the V.A.C. system for negative-pressure wound therapy, PREVENA for surgical incision management, and ABTHERA for open-abdomen therapy. In 2019, 3M announced its acquisition of Acelity. After the transaction was completed, Acelity ceased operating as an independent company and its related products and operations were integrated into 3M’s healthcare business. The company’s principal historical transition was therefore from a specialist wound-care business to a business incorporated into a larger healthcare and industrial group.

• 2019

  3M Acquires Acelity

  3M announced and completed the acquisition of Acelity, and Acelity's advanced wound care business was subsequently integrated into 3M's healthcare business.

Advanced wound care, negative pressure therapy, and related medical technology solutions in hospital and surgical settings

• Negative Pressure Wound Therapy

  V.A.C.

  V.A.C. was a representative negative-pressure wound therapy product line associated with Acelity. It used controlled negative pressure to support the management of complex wounds and was primarily intended for hospitals and other professional healthcare settings.

• Surgical Incision Management

  PREVENA

  PREVENA is a surgical incision management product line intended for postoperative incision care and related risk management. It formed an important part of Acelity’s advanced wound-care business.

• Open Abdomen Therapy

  ABTHERA

  ABTHERA is intended for open-abdomen therapy and provides a negative-pressure treatment approach for complex abdominal wounds or postoperative management, primarily in hospital surgical and critical-care environments.

• 2019

  Acquired and Integrated by 3MM&A

  Background

  Acelity had a portfolio of advanced wound care and negative pressure therapy products, and 3M wanted to expand its healthcare business.

  Action taken

  3M announced the acquisition of Acelity and its related businesses, and upon completion of the transaction, integrated the business into 3M's healthcare system.

  Aftermath

  Acelity no longer operates as an independent company, and its related products and business were transferred to 3M.